中文

Ranitidine Hydrochloride Capsules

【Specification】0.15g

【Approval Number】CFDA NO. H20053397

【Chinese Medical Insurance Category】A

【Validity】24 months

【Indications】For treatment of duodenal ulcers, gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome and other diseases associated with high gastric acid secretion.

【Administration and Dosage】(1) Oral administration. 2 times a day with 150mg (1 capsule) each time, or 300mg (2 capsules) once a day before bedtime. (2) Maintenance therapy: 150mg (1 capsule) once every night for oral administration. (3) Patients with severe nephropathy: the longer the elimination half-life of ranitidine, the lower the dosage; 2 times a day with 75mg (half a capsule) each time. (4) Treatment of Zollinger-Ellison syndrome: large doses recommended; 600-1, 200mg (4-8 capsules) a day.

 

The drug instructions above are for drugs sold in the mainland of the People's Republic of China only. For any updated information, please refer to the latest versions approved by the China Food and Drug Administration. The instructions are not drug ads, and are only a reference for pharmacist and physician professionals. The information contained on the website is provided as a source of knowledge only, and should not replace medical advice from and medical consultation with doctors or other eligible medical professionals. The information on the page should not be used for the diagnosis of diseases.
Copyright © 2017 Chunfeng Pharmaceutical. All rights reserved. Beijing ICP No. 17022283